Purushottamachar Puranik

Title: Purushottamachar Puranik: Innovator in Cancer Treatment

Introduction

Purushottamachar Puranik is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment, holding 2 patents that focus on innovative methods for combating pancreatic cancer and developing novel galeterone analogs.

Latest Patents

His latest patents include a method for the production of novel galeterone analogs and uses thereof. Galeterone and its C-3 analogs are of substantial interest due to their multi-target anticancer activities, including androgen receptor and Mnk degrading activities. The patent provides novel procedures for gram-scale, high-yield synthesis of C-3 analogs of galeterone, such as 3β-(1H-imidazole-1-yl)-17-(1H-benzimidazole-1-yl)-androsta-5,16-diene and 3β-(pyridine-4-ylmethoxy)-17-(1H-benzimidazol-1-yl)androsta-5,16-diene. Additionally, he has developed methods for treating pancreatic cancer, which may be resistant to other therapeutic regimens. These methods involve administering ARDA compounds to the subject in need.

Career Highlights

Purushottamachar Puranik has worked with esteemed organizations such as the University System of Maryland and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute significantly to research and development in the medical field.

Collaborations

He has collaborated with notable coworkers, including Vincent C. O. Njar and Andrew K. Kwegyir-Afful, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Purushottamachar Puranik's innovative work in cancer treatment and his contributions to the development of novel therapeutic methods highlight his importance as an inventor in the medical field. His patents reflect a commitment to advancing healthcare solutions for challenging conditions like pancreatic cancer.